MCK Stock - McKesson Corporation
Unlock GoAI Insights for MCK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $359.05B | $308.95B | $276.71B | $263.97B | $238.23B |
| Gross Profit | $12.48B | $12.20B | $11.87B | $12.65B | $11.58B |
| Gross Margin | 3.5% | 3.9% | 4.3% | 4.8% | 4.9% |
| Operating Income | $4.37B | $3.93B | $4.45B | $2.72B | $3.51B |
| Net Income | $3.29B | $3.00B | $3.56B | $1.11B | $-4,539,000,000 |
| Net Margin | 0.9% | 1.0% | 1.3% | 0.4% | -1.9% |
| EPS | $25.86 | $22.54 | $25.23 | $7.31 | $-27.02 |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Visit WebsiteEarnings History & Surprises
MCKEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $9.19 | — | — | — |
Q4 2025 | Nov 5, 2025 | $9.03 | $9.86 | +9.2% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $8.14 | $8.26 | +1.5% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $9.83 | $10.12 | +3.0% | ✓ BEAT |
Q1 2025 | Feb 5, 2025 | $8.60 | $8.03 | -6.6% | ✗ MISS |
Q4 2024 | Nov 6, 2024 | $6.88 | $7.07 | +2.8% | ✓ BEAT |
Q3 2024 | Aug 7, 2024 | $7.21 | $7.88 | +9.3% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $6.34 | $6.18 | -2.5% | ✗ MISS |
Q1 2024 | Feb 7, 2024 | $7.04 | $7.74 | +9.9% | ✓ BEAT |
Q4 2023 | Nov 1, 2023 | $6.15 | $6.23 | +1.3% | ✓ BEAT |
Q3 2023 | Aug 2, 2023 | $5.87 | $7.27 | +23.9% | ✓ BEAT |
Q2 2023 | May 8, 2023 | $7.17 | $7.19 | +0.3% | ✓ BEAT |
Q1 2023 | Feb 1, 2023 | $6.35 | $6.90 | +8.7% | ✓ BEAT |
Q4 2022 | Nov 1, 2022 | $6.09 | $6.06 | -0.5% | ✗ MISS |
Q3 2022 | Aug 3, 2022 | $5.28 | $5.83 | +10.4% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $6.06 | $5.83 | -3.8% | ✗ MISS |
Q1 2022 | Feb 2, 2022 | $5.38 | $6.15 | +14.3% | ✓ BEAT |
Q4 2021 | Nov 1, 2021 | $4.67 | $6.15 | +31.7% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $4.09 | $5.56 | +35.9% | ✓ BEAT |
Latest News
Frequently Asked Questions about MCK
What is MCK's current stock price?
What is the analyst price target for MCK?
What sector is McKesson Corporation in?
What is MCK's market cap?
Does MCK pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MCK for comparison